270 related articles for article (PubMed ID: 36197017)
1. Genetic deletion of the nuclear factor of activated T cells 5 in collecting duct principal cells causes nephrogenic diabetes insipidus.
Petrillo F; Chernyakov D; Esteva-Font C; Poulsen SB; Edemir B; Fenton RA
FASEB J; 2022 Nov; 36(11):e22583. PubMed ID: 36197017
[TBL] [Abstract][Full Text] [Related]
2. P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.
Zhang Y; Peti-Peterdi J; Müller CE; Carlson NG; Baqi Y; Strasburg DL; Heiney KM; Villanueva K; Kohan DE; Kishore BK
J Am Soc Nephrol; 2015 Dec; 26(12):2978-87. PubMed ID: 25855780
[TBL] [Abstract][Full Text] [Related]
3. Integrin-linked kinase regulates tubular aquaporin-2 content and intracellular location: a link between the extracellular matrix and water reabsorption.
Cano-Peñalver JL; Griera M; Serrano I; Rodríguez-Puyol D; Dedhar S; de Frutos S; Rodríguez-Puyol M
FASEB J; 2014 Aug; 28(8):3645-59. PubMed ID: 24784577
[TBL] [Abstract][Full Text] [Related]
4. Sickle cell disease up-regulates vasopressin, aquaporin 2, urea transporter A1, Na-K-Cl cotransporter 2, and epithelial Na channels in the mouse kidney medulla despite compromising urinary concentration ability.
Wang H; Morris RG; Knepper MA; Zhou X
Physiol Rep; 2019 Apr; 7(8):e14066. PubMed ID: 31033226
[TBL] [Abstract][Full Text] [Related]
5. AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus.
Ando F; Mori S; Yui N; Morimoto T; Nomura N; Sohara E; Rai T; Sasaki S; Kondo Y; Kagechika H; Uchida S
Nat Commun; 2018 Apr; 9(1):1411. PubMed ID: 29650969
[TBL] [Abstract][Full Text] [Related]
6. Effect of the cGMP pathway on AQP2 expression and translocation: potential implications for nephrogenic diabetes insipidus.
Boone M; Kortenoeven M; Robben JH; Deen PM
Nephrol Dial Transplant; 2010 Jan; 25(1):48-54. PubMed ID: 19666909
[TBL] [Abstract][Full Text] [Related]
7. Kidney collecting duct-derived vasopressin is not essential for appropriate concentration or dilution of urine.
Zuchowski Y; Carty JS; Trapani JB; Watts JA; Bock F; Zhang M; Terker AS; Zent R; Delpire E; Harris RC; Arroyo JP
Am J Physiol Renal Physiol; 2024 Jun; 326(6):F1091-F1100. PubMed ID: 38695074
[TBL] [Abstract][Full Text] [Related]
8. Activation of AQP2 water channels by protein kinase A: therapeutic strategies for congenital nephrogenic diabetes insipidus.
Ando F
Clin Exp Nephrol; 2021 Oct; 25(10):1051-1056. PubMed ID: 34224008
[TBL] [Abstract][Full Text] [Related]
9. Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.
Milano S; Carmosino M; Gerbino A; Svelto M; Procino G
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125546
[TBL] [Abstract][Full Text] [Related]
10. Nephrogenic diabetes insipidus in mice caused by deleting COOH-terminal tail of aquaporin-2.
Shi PP; Cao XR; Qu J; Volk KA; Kirby P; Williamson RA; Stokes JB; Yang B
Am J Physiol Renal Physiol; 2007 May; 292(5):F1334-44. PubMed ID: 17229678
[TBL] [Abstract][Full Text] [Related]
11. AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.
Gao C; Higgins PJ; Zhang W
Cells; 2020 Sep; 9(10):. PubMed ID: 32993088
[TBL] [Abstract][Full Text] [Related]
12. V2R mutations and nephrogenic diabetes insipidus.
Bichet DG
Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
[TBL] [Abstract][Full Text] [Related]
13. A mini-review of pharmacological strategies used to ameliorate polyuria associated with X-linked nephrogenic diabetes insipidus.
Mortensen LA; Bistrup C; Jensen BL; Hinrichs GR
Am J Physiol Renal Physiol; 2020 Nov; 319(5):F746-F753. PubMed ID: 32924547
[TBL] [Abstract][Full Text] [Related]
14. Arginase-II negatively regulates renal aquaporin-2 and water reabsorption.
Huang J; Montani JP; Verrey F; Feraille E; Ming XF; Yang Z
FASEB J; 2018 Oct; 32(10):5520-5531. PubMed ID: 29718707
[TBL] [Abstract][Full Text] [Related]
15. Nephrogenic Diabetes Insipidus.
Balla A; Hunyady L
Exp Suppl; 2019; 111():317-339. PubMed ID: 31588538
[TBL] [Abstract][Full Text] [Related]
16. Elf5 is a principal cell lineage specific transcription factor in the kidney that contributes to Aqp2 and Avpr2 gene expression.
Grassmeyer J; Mukherjee M; deRiso J; Hettinger C; Bailey M; Sinha S; Visvader JE; Zhao H; Fogarty E; Surendran K
Dev Biol; 2017 Apr; 424(1):77-89. PubMed ID: 28215940
[TBL] [Abstract][Full Text] [Related]
17. Adenylate cyclase 6 determines cAMP formation and aquaporin-2 phosphorylation and trafficking in inner medulla.
Rieg T; Tang T; Murray F; Schroth J; Insel PA; Fenton RA; Hammond HK; Vallon V
J Am Soc Nephrol; 2010 Dec; 21(12):2059-68. PubMed ID: 20864687
[TBL] [Abstract][Full Text] [Related]
18. Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus.
Olesen ET; Rützler MR; Moeller HB; Praetorius HA; Fenton RA
Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12949-54. PubMed ID: 21768374
[TBL] [Abstract][Full Text] [Related]
19. Fluconazole Increases Osmotic Water Transport in Renal Collecting Duct through Effects on Aquaporin-2 Trafficking.
Vukićević T; Hinze C; Baltzer S; Himmerkus N; Quintanova C; Zühlke K; Compton F; Ahlborn R; Dema A; Eichhorst J; Wiesner B; Bleich M; Schmidt-Ott KM; Klussmann E
J Am Soc Nephrol; 2019 May; 30(5):795-810. PubMed ID: 30988011
[TBL] [Abstract][Full Text] [Related]
20. New autosomal recessive mutations in aquaporin-2 causing nephrogenic diabetes insipidus through deficient targeting display normal expression in Xenopus oocytes.
Leduc-Nadeau A; Lussier Y; Arthus MF; Lonergan M; Martinez-Aguayo A; Riveira-Munoz E; Devuyst O; Bissonnette P; Bichet DG
J Physiol; 2010 Jun; 588(Pt 12):2205-18. PubMed ID: 20403973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
